Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice
Yan Liu, Xiaodan Zong, Jie Huang, et al.
Aging (2019) Vol. 11, Iss. 14, pp. 5008-5034
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The Role of the GABAergic System in Diseases of the Central Nervous System
Wen Zhang, Bingrui Xiong, Long-Qing Zhang, et al.
Neuroscience (2021) Vol. 470, pp. 88-99
Closed Access | Times Cited: 66
The anti-aging mechanism of ginsenosides with medicine and food homology
Tiantian Tian, Chung-Nga Ko, Wenya Luo, et al.
Food & Function (2023) Vol. 14, Iss. 20, pp. 9123-9136
Closed Access | Times Cited: 25
CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer’s disease mice
Yuanyu Shen, Xiaolei Zhang, Si-qi Liu, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases
Liang Gong, Jiayi Yin, Yu Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Divya Yadav, Pravir Kumar
Neurochemistry International (2022) Vol. 156, pp. 105327-105327
Closed Access | Times Cited: 33
Progress of Ginsenoside Rb1 in neurological disorders
Gongxia Ling, Min Zhang, Chizhang Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Generation of a Novel Mouse Model of Parkinson’s Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra
Yunlong Zhang, Xingjun Meng, Zhigang Jiao, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 3, pp. 406-417
Closed Access | Times Cited: 45
Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling
Yan Liu, Shan Wang, Jun Kan, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 4, pp. 260-276
Open Access | Times Cited: 44
Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease
Zeng-Ping Kang, Youbao Zhonga, Tiantian Wu, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 3, pp. 700-711
Open Access | Times Cited: 35
Ginsenoside and Its Therapeutic Potential for Cognitive Impairment
Hui Feng, Xue Mei, Hao Deng, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1310-1310
Open Access | Times Cited: 27
Microglial targeted therapy relieves cognitive impairment caused by Cntnap4 deficiency
Wenlong Zhang, Huaqing Chen, Liuyan Ding, et al.
Exploration (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 13
Brain plasticity and ginseng
Myoung‐Sook Shin, Young‐Joo Lee, Ik‐Hyun Cho, et al.
Journal of Ginseng Research (2024) Vol. 48, Iss. 3, pp. 286-297
Open Access | Times Cited: 5
Modified Huang-Lian-Jie-Du Decoction Ameliorates Aβ Synaptotoxicity in a Murine Model of Alzheimer’s Disease
Yan Liu, Ting Du, Wenlong Zhang, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-27
Open Access | Times Cited: 36
Amelioration of olfactory dysfunction in a mouse model of Parkinson’s disease via enhancing GABAergic signaling
Xingyang Liu, Ke Wang, Xianhua Deng, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Ginsenosides Rg1, Rb1 and rare ginsenosides: promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
Mingchun Jiang, Jiaxin Chi, Yifan Qiao, et al.
Pharmacological Research (2025) Vol. 212, pp. 107578-107578
Open Access
CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes
Wenlong Zhang, Miaomiao Zhou, Weiye Lu, et al.
Theranostics (2020) Vol. 10, Iss. 7, pp. 3000-3021
Open Access | Times Cited: 28
Pharmacodynamical research of extracts and compounds in traditional Chinese medicines for Parkinson's disease
Mengmeng Li, Hanze Wang, Yuxin Bai, et al.
Fitoterapia (2024) Vol. 177, pp. 106086-106086
Closed Access | Times Cited: 3
Lactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice
Wenlong Zhang, Jie Huang, Feng Gao, et al.
EBioMedicine (2022) Vol. 86, pp. 104323-104323
Open Access | Times Cited: 13
Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease
Yingying Ding, Benson O. A. Botchway, Yong Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 12, pp. 5537-5550
Closed Access | Times Cited: 7
Combined non-targeted and targeted metabolomics reveals the mechanism of delaying aging of Ginseng fibrous root
Xiang Yang, Xiang Yang, Bo Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases
Jinping Liang, Yuchen Zhu, Shasha Liu, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 2
Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease
Linlin Han, Jiaying Lu, Yilin Tang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 14
Single-dose L-dopa increases upper brainstem GABA in Parkinson's disease: A preliminary study
Yulu Song, Tao Gong, Yuanyuan Xiang, et al.
Journal of the Neurological Sciences (2021) Vol. 422, pp. 117309-117309
Closed Access | Times Cited: 13
Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
Xiang Li, Wenjun Wang, Jianghong Yan, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 13
4,4′-Dimethoxychalcone regulates redox homeostasis by targeting riboflavin metabolism in Parkinson's disease therapy
Junwei Gong, Wenlong Zhang, Liuyan Ding, et al.
Free Radical Biology and Medicine (2021) Vol. 174, pp. 40-56
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top